[{"Assets_0_Q1_USD":"11639600000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.19","CommonStockSharesConverted_0_Q1_shares":"139700000.0","CommonStockSharesOutstanding_0_Q1_shares":"139700000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.57","EarningsPerShareDiluted_1_Q1_USD":"0.57","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","MinorityInterest_0_Q1_USD":"200000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"172400000.0","NetIncomeLoss_1_Q1_USD":"80800000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q1_USD":"1217000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"6205600000.0","StockholdersEquity_0_Q1_USD":"6205400000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"141400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"140800000.0","filed":"20180508","footnote":null,"form":"10-Q","fp":"Q1","fy":"2018.0","name":"PERRIGO CO PLC","period":"20180331","qtrs":"0","uom":"USD"}]